Brief: Imaging Biometrics Announces Completion Of Phase 1 Trial Of GaM
10/11/2025 18:18
Nov 10 (Reuters) - Imaging Biometrics Ltd IBAI.L: IMAGING BIOMETRICS - IB ANNOUNCES COMPLETION OF PHASE 1 TRIAL OF GAM IMAGING BIOMETRICS LTD - TRIAL MEETS PHASE 1 OBJECTIVES WITH NO SIGNIFICANT ADVERSE EVENTS IMAGING BIOMETRICS LTD - TO INITIATE PHASE 2 TRIAL FOR GAM EFFICACY Source text: ID:nRSJ9232Ga Further company coverage: IBAI.L ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Imaging Biometrics
See all newsImaging Biometrics - US Academic Medical Centre Adopts IB Clinic
Imaging Biometrics - Half Yearly Report to 30 June 2026
Imaging Biometrics - Sub-division
Brief: Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day
Brief: Imaging Biometrics Says Expectation Of Progress Towards Profitability In 2026 Is Unchanged